Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy.
Saved in:
| Title: | Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy. |
|---|---|
| Authors: | Jiang M; Department of Pediatrics, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Fan J; Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China., Qu X; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Li S; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO), Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Clayton, VIC, Australia., Nilsson SK; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO), Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Clayton, VIC, Australia., Sun YBY; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Chen Y; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia., Yu D; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia., Liu D; Institute of Nephrology, Zhong Da Hospital, Southeast University, Nanjing, China., Liu BC; Institute of Nephrology, Zhong Da Hospital, Southeast University, Nanjing, China., Tang M; Key Laboratory for Developmental Genes and Human Disease, Ministry of Education, Institute of Life Sciences, Southeast University, Nanjing, China., Chen W; Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China., Ren Y; Florida State University College of Medicine, Tallahassee, FL, United States., Nikolic-Paterson DJ; Department of Nephrology, Monash Health and Monash University Department of Medicine, Clayton, VIC, Australia., Jiang X; Department of Pediatrics, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Li J; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.; The Second Clinical College and Shunde Women and Children Hospital, Guangdong Medical University, Shunde, China., Yu X; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.; The Second Clinical College and Shunde Women and Children Hospital, Guangdong Medical University, Shunde, China.; Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangzhou, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2019 Aug 09; Vol. 10, pp. 880. Date of Electronic Publication: 2019 Aug 09 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2019.00880 |
